Zimmer Biomet Holdings
- Market cap
- 16.88B
- P/E (TTM)i
- 21.48
- P/Bi
- 1.34
- EPSi
- 3.55
- Div yieldi
- 1.08%
- 52W posi
- 36%
Anonymous reader poll. Unscientific, not investment advice.
Zimmer Biomet Holdings ended the session at 88.49, down 1.33%. Its market capitalisation is about 16.88B, the #1040 most valuable US-listed company we track. The trailing P/E of 21.56 is 54% below its five-year average of 46.57. Income-focused holders are looking at a trailing yield of 1.08% here. Across 17 analysts the consensus rating is Buy, with an average price target of 106.93 (+21%). Over the past year the stock has ranged from 78.70 to 105.75; it now sits 36% up that band.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 5 months.
- Recent price momentum is -5.2% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has fallen to 4.5% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation B+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 22.2x | Better than 42% |
| Forward P/E | 17.5x | Better than 50% |
| Price / Sales | 2.0x | Better than 64% |
| P/E vs own 5-yr range | 12th pctl | Better than 85% |
Growth B+
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 5.9% | Better than 48% |
| Net income CAGR (3Y) | 45.0% | Better than 89% |
| Free cash flow CAGR (3Y) | 10.0% | Better than 50% |
Profitability C+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 69.7% | Better than 83% |
| Operating margin | 16.5% | Better than 55% |
| Net margin | 8.6% | Better than 41% |
| Return on equity | 5.6% | Better than 22% |
| Return on invested capital | 4.9% | Better than 27% |
Momentum B-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 2.7% | Better than 62% |
| 6-month return | 0.7% | Better than 40% |
| 12-month return (ex latest month) | 0.0% | Better than 32% |
| Distance below 52-week high | 13.4% | Better than 65% |
Financial Health B
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 2.0x | Better than 67% |
| Debt to assets | 32.6% | Better than 47% |
| Interest coverage | 3.8x | Better than 34% |
| Free cash flow / net income | 201.4% | Better than 83% |
Analyst View D+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 35.3% | Better than 17% |
| Upside to average target | 16.8% | Better than 32% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 89.68
- Open
- 89.11
- Day range
- 88.32 - 90.01
- Avg price
- 88.89
- Volume
- 1.99M
- Turnover
- 177.01M
- Turnover ratei
- 1.05%
- Volume ratioi
- 0.92
- Amplitudei
- 1.88%
- 52-week rangei
- 78.70 - 105.75
Valuation
- P/Ei
- 24.93
- P/E (TTM)i
- 21.48
- P/Bi
- 1.34
- EPSi
- 3.55
- Book value / shi
- 66.19
- Net profit
- 677.12M
- Net assets
- 12.62B
Share structure
- Market cap
- 16.88B
- Float capi
- 16.83B
- Shares out
- 190.74M
- Float sharesi
- 190.13M
Dividend & listing
- Div yield (TTM)i
- 1.08%
- Dividend (TTM)
- 0.96
- Listing date
- 1970-01-01
16.3% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-51.55M net over the window
Short interest
- Shares short
- 8.58M
- % of floati
- 4.50%
- Days to coveri
- 4.40
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Zimmer Biomet Holdings (ZBH)?
Zimmer Biomet Holdings last traded at 88.49. The quote on this page refreshes every few seconds while US markets are open.
What is Zimmer Biomet Holdings's market cap?
About 16.88B.
What is the P/E ratio of Zimmer Biomet Holdings?
The trailing twelve-month P/E is 21.48, below its own 5-year average of 46.57 — toward the bottom of its historical range (12.29% percentile). See the Valuation tab for the full history.
Does Zimmer Biomet Holdings pay a dividend?
Yes. The trailing dividend yield is 1.08%. Per-share dividends have risen or held for 10 straight years through 2025. See the Dividends tab for the full payment history.
Is Zimmer Biomet Holdings a buy according to analysts?
The consensus of 17 analysts is a Buy rating, with an average 12-month price target of 106.93, which implies 20.8% upside from the current price. This is not investment advice.
What is Zimmer Biomet Holdings's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Zimmer Biomet Holdings a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-07 20:02:42 · For reference only, not investment advice and not tailored to your situation.